Purging of tumor cells from leukapheresis products: Experimental and clinical aspects

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 4, 1996, Pages 427-436

  Kvalheim, Gunnar ^a   Wang, Meng Yu ^a   Pharo, Anne ^a   Holte, Harald ^a   Jacobsen, Erling ^a   Beiske, Klaus ^a   Kvaløy, Stein ^a   Smeland, Erlend ^a   Funderud, Steinar ^a   Fodstad, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CANCER ANTIBODY; CD34 ANTIGEN; IMMUNOTOXIN; T LYMPHOCYTE ANTIBODY;

ARTICLE; AUTOGRAFT; BONE MARROW PURGING; BREAST CANCER; CONTAMINATION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; LYMPHOMA; LYMPHOMA CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TUMOR CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PRESERVATION; BONE MARROW PURGING; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; LYMPHOCYTE SUBSETS; LYMPHOMA; MALE; MICROSPHERES; NEOPLASM CIRCULATING CELLS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029738598     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.427     Document Type: Article

References (31)

1. International Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem Cell Transplantation in Malignancies. Conclusions from the jury. Lyon, 1993. Ann. Oncol. (Suppl. 1) 4:1, 1993.
2. Shpall, E.J. & Jones, R.B. Release of tumor cells from bone marrow. Blood 83:623, 1994.
3. Ross, A.A., Cooper, B.W., Lazarus, H.M. et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
4. Negrin, R.S. & Pesando, J. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J. Clin. Oncol. 12:1021, 1994.
5. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
6. Brenner, M.K., Rill, D.R., Moen, R.C., et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993.
7. Deisseroth, A., Zu, Z., Claxton, D., et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994.
8. Gribben, J.G., Freedman, A.S., Neuberg, D., et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 28:1525, 1991.
9. Kvalheim, G., Fodstad, O., Pihl, A., et al. Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res. 47:846, 1987.
10. Wang, M.Y., Fodstad, O., Luwig, W.D., et al. An effective, direct immunomagnetic procedure for purging acute lymphoblastic leukemia cells from human bone marrow. Pathol. Oncol. Res. 1:32, 1995.
11. Vartdal, F., Kvalheim, G., Lea, T.E., et al. Depletion of T-lymphocytes from human bone marrow. Transplantation 43:366, 1987.
12. Kvalheim, G., Sørensen, O., Fodstad, Ø., et al. Immunomagnetic removal of B-lymphoma cells from human bone marrow: A procedure for clinical use. Bone Marrow Transplant. 3:31, 1988.
13. Wang, M.Y., Kvalheim, G., Kvaløy, S., et al. An effective immuno-magnetic method for bone marrow purging in T cell malignancies. Bone Marrow Transplant. 9:319, 1992.
14. Kvalheim, G., Funderud, S., Kvaløy, S., et al. Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation. J. Natl. Cancer. Inst. 80:1322, 1988.
15. Kvalheim, G., Jakobsen, E., Holte, H., et al. Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged with immunomagnetic beads. In Advances in Bone Marrow Purging and Processing, eds. Gee, A.P., Gross, S. and Worthington-White, D.A. Wiley-Liss, New York, 1994, p.133.
16. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
17. McMichael, A., Beverly, P.C.L., Hogg, N., et al., eds. Leucocyte Typing III. White Cell Differentiation Antigens. Oxford University Press, Oxford, 1987.
18. Knapp, W., Dörken, B., Gilks, W.R., Rieber, E.P., Schmidt, R.E., Stein, H., Kr. von dem Borne, A.E.G. eds. In Leucocyte Typing IV. White Cell Differentiation Antigens. Oxford University Press, Oxford, 1989.
19. Kiesel, S., Haas, R., Moldenhauer, G., et al. Removal of cells from malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated ctyolysis. Leukemia Res. 11:11, 1987.
20. Fodstad, Ø., Kvalheim, G., Pihl, A., et al. New indirect approach to the therapeutic use of immunotoxins. J. Natl. Cancer Inst. 80:439, 1988.
21. Kvalheim, G. Immunomagnetic removal ex vivo of malignant B-cells from human bone marrow. Thesis. University of Oslo, 1989.
22. Myklebust, A.T., Godal, A., Juell, S., et al. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res. 54:209, 1994.
23. Haas, R., Mohle, R., Fruehauf, S., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells (PBPC) in malignant lymphoma. Blood 83:3787, 1994.
24. Bensinger, W., Appelbaum, F., Rowley, S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Blood 13:2547, 1995.
25. Straka, C., Dorken, B. & Kvalheim, G. Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic non-Hodgkin's lymphoma. Blood 15:2688, 1992.
26. EBMT Working Party Trial. European CUP Trial. A randomised trial comparing efficacy of chemotherapy with purged or unpurged autologous transplantation in adults with poor-risk relapsed follicular non-Hodgkin's lymphoma. Third revised version, March 1995.
27. Sutherland, H.J., Eaves, A.C. & Eaves, C.J. Quantitative assays of human hemopoietic progenitor cells. In Bone Marrow Processing and Purging: A Practical Guide, ed. Gee, A.P. CRC Press, Boca Raton, FL, 1991, p. 155.
28. Berenson, R.J., Bensinger, W.I., Hill, R.S., et al. Engraftment after infusion of CD34-positive marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991.
29. Kvalheim, G., Pharo, A. & Holte, H. The use of immunomagnetic beads and ISOLEX 300 gives high purity and yield of CD34+ cells from peripheral blood progenitor cell products. Bone Marrow Transplant. 17 (Suppl. 1):57,1996.
30. Law, P., Ishizawa, L., Gee, A., et al. Selection of CD34+ cells for large quantities of human bone marrow by immunomagnetic procedures. Exp. Hematol. 20:740, 1992.
31. Verbik, D.J., Jackson, J.D., Pirruccello, S.J., et al. Functional and phenotypic characterization of human peripheral blood stem cell harvests: A comparative analysis of cells from consecutive collections. Blood 85:1964,1995.